Filtros de búsqueda

Lista de obras de

68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer

scientific article published on 06 April 2019

9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium

artículo científico publicado en 2012

A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial

artículo científico publicado en 2020

A biomarker-enriched, randomized Phase II trial of adavosertib (AZD1775) plus paclitaxel and carboplatin for women with platinum-sensitive TP53-mutant ovarian cancer

artículo científico publicado en 2020

A low-frequency haplotype spanning SLX4/FANCP constitutes a new risk locus for early-onset breast cancer (<60 years) and is associated with reduced DNA repair capacity

artículo científico publicado en 2017

A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52).

artículo científico publicado en 2015

A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA)

scientific article published on 01 April 2019

ABC3 Consensus: Assessment by a German Group of Experts

artículo científico publicado en 2016

ASCO 2019: New Results in Breast Cancer

scientific article published on 06 August 2019

Aesthetic and functional results after breast conserving surgery as correlates of quality of life measured by a German version of the Breast Cancer Treatment Outcome Scale (BCTOS).

artículo científico publicado en 2010

An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression

artículo científico publicado en 2016

Androgen receptor expression and response to chemotherapy in breast cancer patients treated in the neoadjuvant TECHNO and PREPARE trial

scientific article published on 15 November 2019

Association of HER2 Overexpression and Prognosis in Small (T1N0) Primary Breast Cancers

artículo científico publicado en 2013

Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21.

scientific article published on 21 October 2016

Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry

artículo científico publicado en 2016

BRCA1-like profile predicts benefit of tandem high dose epirubicin-cyclophospamide-thiotepa in high risk breast cancer patients randomized in the WSG-AM01 trial

artículo científico publicado en 2016

BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer

artículo científico publicado en 2017

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

artículo científico publicado en 2015

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

artículo científico publicado en 2020

Body fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via Toll-like receptor signaling

artículo científico publicado en 2013

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.

artículo científico publicado en 2016

Breast cancers with a BRCA1-like DNA copy number profile recur less often than expected after high-dose alkylating chemotherapy.

artículo científico publicado en 2014

CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer

artículo científico publicado en 2011

CD24 polymorphisms in breast cancer: impact on prognosis and risk ⬇️

artículo científico publicado el 13 de enero de 2013

CDK4/6 Inhibitors in the Treatment of Metastatic Breast Cancer

artículo científico publicado en 2017

CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer

artículo científico publicado en 2012

COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer

artículo científico publicado en 2018

Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk

artículo científico publicado en 2015

Clinical Relevance of Collagen Protein Degradation Markers C3M and C4M in the Serum of Breast Cancer Patients Treated with Neoadjuvant Therapy in the GeparQuinto Trial

artículo científico publicado en 2019

Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer

artículo científico publicado en 2017

Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer

artículo científico publicado en 2011

DNA methylation array analyses identified breast cancer-associatedHYAL2methylation in peripheral blood

DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA.

artículo científico publicado en 2016

Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883)

artículo científico publicado en 2019

Design and development of 99mTc labeled FAPI-tracers for SPECT-imaging and 188Re therapy

artículo científico publicado en 2020

Determination of paraneoplastic autoimmune responses by tumor cell biology and intratumoral IFN-alpha/IL-12 in breast cancer patients

artículo científico publicado en 2010

Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor Retention

artículo científico publicado en 2019

Diagnosis of Li-Fraumeni Syndrome: Differentiating TP53 germline mutations from clonal hematopoiesis: Results of the observational AGO-TR1 trial

artículo científico publicado en 2018

Double-Blind, Placebo-Controlled, Randomized Phase III Trial Evaluating Pertuzumab Combined With Chemotherapy for Low Tumor Human Epidermal Growth Factor Receptor 3 mRNA-Expressing Platinum-Resistant Ovarian Cancer (PENELOPE).

artículo científico publicado en 2016

Doxorubicin/Pemetrexed Followed by Docetaxel Versus Doxorubicin/Cyclophosphamide Followed by Docetaxel as Neoadjuvant Treatment for Early-Stage Breast Cancer: A Randomized Phase II Trial

artículo científico publicado en 2007

Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer etc.

artículo científico publicado en 2018

Efficacy and toxicity profile of pegylated liposomal doxorubicin (Caelyx) in patients with advanced breast cancer

artículo científico publicado en 2014

Efficacy of nab-paclitaxel does not seem to be associated with SPARC expression in metastatic breast cancer

artículo científico publicado en 2014

Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation

artículo científico publicado en 2014

Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

scientific article published on 03 September 2016

Extracapsular Lymph Node Involvement in Ovarian Carcinoma

artículo científico publicado en 2019

Fibroblast growth factor receptor 4 (FGFR4) as detected by immunohistochemistry is associated with postoperative residual disease in ovarian cancer

scientific article published on 05 August 2019

Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer

artículo científico publicado en 2012

Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus

artículo científico publicado en 2016

Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.

artículo científico publicado en 2015

Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk

artículo científico publicado en 2014

Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer

artículo científico publicado en 2016

Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk

artículo científico publicado en 2015

Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.

artículo científico publicado en 2014

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

artículo científico publicado en 2016

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers

artículo científico publicado en 2013

Genetic modifiers of CHEK2*1100delC-associated breast cancer risk

scientific article published on 06 October 2016

Genetic predisposition to ductal carcinoma in situ of the breast

artículo científico publicado en 2016

Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk

artículo científico publicado en 2010

Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

artículo científico publicado en 2014

Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium

artículo científico publicado en 2015

Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent

artículo científico publicado en 2016

Genome-wide association analysis identifies three new breast cancer susceptibility loci

artículo científico publicado en 2012

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

artículo científico publicado en 2015

Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization

artículo científico publicado en 2015

Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy

scientific article published on 11 December 2019

Humoral response to catumaxomab correlates with clinical outcome: results of the pivotal phase II/III study in patients with malignant ascites

artículo científico publicado en 2011

Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk

artículo científico publicado en 2014

Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

artículo científico publicado en 2013

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

artículo científico publicado en 2016

Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

artículo científico publicado en 2016

Immunooncology in Breast Cancer: Active and Passive Vaccination Strategies

Immunotherapy in Breast Cancer

artículo científico publicado en 2016

Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer

artículo científico publicado en 2015

Invasive ductal breast cancer within a malignant phyllodes tumor: case report and assessment of clonality

artículo científico publicado en 2009

Large-scale genotyping identifies 41 new loci associated with breast cancer risk

artículo científico publicado en 2013

Locoregional risk assessment after neoadjuvant chemotherapy in patients with primary breast cancer: clinical utility of the CPS + EG score

artículo científico publicado en 2019

Loss of Drop1 expression already at early tumor stages in a wide range of human carcinomas

artículo científico publicado en 2008

Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage

artículo científico publicado en 2011

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium

artículo científico publicado en 2011

Luminal Metastatic Breast Cancer

artículo científico publicado en 2019

Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications

artículo científico publicado en 2016

Mismatch Repair Deficiency Drives Durable Complete Remission by Targeting Programmed Death Receptor 1 in a Metastatic Luminal Breast Cancer Patient

scientific article published on 14 November 2018

Molecular Tumor Boards

artículo científico publicado en 2018

Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis

artículo científico publicado en 2010

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

artículo científico publicado en 2013

Nab-Paclitaxel monotherapy as a treatment of patients with metastatic breast cancer in routine clinical practice

artículo científico

Neoadjuvant epirubicin, gemcitabine and docetaxel for primary breast cancer: Long‐term survival data and major prognostic factors based on two consecutive neoadjuvant phase I/II trials ⬇️

artículo científico publicado el 16 de marzo de 2013

Niraparib Maintenance Treatment Improves Time Without Symptoms or Toxicity (TWiST) Versus Routine Surveillance in Recurrent Ovarian Cancer: A TWiST Analysis of the ENGOT-OV16/NOVA Trial

scientific article published on 16 September 2019

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

artículo científico publicado en 2015

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer

scientific article published on 01 December 2019

Omission of axillary dissection according to ACOSOG Z0011: impact on adjuvant treatment recommendations

artículo científico publicado en 2013

Outcome after neoadjuvant chemotherapy in estrogen receptor-positive and progesterone receptor-negative breast cancer patients: a pooled analysis of individual patient data from ten prospectively randomized controlled neoadjuvant trials

artículo científico publicado en 2017

Personalized therapy in breast cancer

artículo científico publicado en 2012

Pertuzumab Plus Chemotherapy for Platinum-Resistant Ovarian Cancer: Safety Run-in Results of the PENELOPE Trial

artículo científico publicado en 2016

Phase 1, open-label, dose-escalation study of sorafenib in combination with eribulin in patients with advanced, metastatic, or refractory solid tumors

artículo científico publicado en 2018

Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer.

artículo científico publicado en 2018

Plasma S100P level as a novel prognostic marker of metastatic breast cancer

artículo científico publicado en 2016

Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancer

artículo científico publicado en 2015

Plasma microRNA panel for minimally invasive detection of breast cancer

artículo científico publicado en 2013

Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression

artículo científico publicado en 2015

Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer ⬇️

artículo científico publicado en 2019

Prediction of breast cancer risk based on profiling with common genetic variants

artículo científico publicado en 2015

Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer: Clinical utility of the MD Anderson Prognostic Index

scientific article published in PLoS ONE

Prediction of pathological complete response in breast cancer patients during neoadjuvant chemotherapy: Is shear wave elastography a useful tool in clinical routine?

scientific article published on 01 May 2020

Predictors of Residual Tumor in Breast-Conserving Therapy

artículo científico publicado en 2015

Predictors of resectability in breast-conserving therapy

artículo científico publicado en 2012

Preeclampsia: increased expression of soluble ADAM 12.

artículo científico publicado en 2005

Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).

artículo científico publicado en 2017

Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study

artículo científico publicado en 2016

Prophylaxis and Management of Skin Toxicities

scientific article published on 15 February 2019

Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

artículo científico publicado en 2018

Re-challenge with catumaxomab in patients with malignant ascites: results from the SECIMAS study

artículo científico publicado en 2014

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

artículo científico publicado en 2014

Relevance of tumour-infiltrating lymphocytes, PD-1 and PD-L1 in patients with high-risk, nodal-metastasised breast cancer of the German Adjuvant Intergroup Node-positive study

scientific article published on 07 May 2019

Risk assessment after neoadjuvant chemotherapy in luminal breast cancer using a clinico-molecular predictor

artículo científico publicado en 2018

SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival

artículo científico publicado en 2015

Second breast conserving therapy after ipsilateral breast tumor recurrence - a 10-year experience of re-irradiation

scientific article published on 29 August 2019

Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients

artículo científico publicado en 2014

Subgroup analysis of patients with HER2-negative metastatic breast cancer in the second-line setting from a phase 3, open-label, randomized study of eribulin mesilate versus capecitabine

artículo científico publicado en 2018

Sustained prognostic impact of circulating tumor cell status and kinetics upon further progression of metastatic breast cancer

artículo científico publicado en 2018

Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes

artículo científico publicado en 2009

T-DM1 as a New Treatment Option for Patients with Metastatic HER2-positive Breast Cancer in Clinical Practice.

artículo científico publicado en 2015

TA-MUC1 as detected by the fully humanized, therapeutic antibody Gatipotzumab predicts poor prognosis in cervical cancer

artículo científico publicado en 2018

TROPiCS-02: A Phase III study investigating sacituzumab govitecan in the treatment of HR+/HER2- metastatic breast cancer

scientific article published on 30 March 2020

Targeted Therapies in Triple-Negative Breast Cancer

artículo científico publicado en 2015

The G protein-coupled estrogen receptor (GPER/GPR30) may serve as a prognostic marker in early-stage cervical cancer.

artículo científico publicado en 2017

The association between breast cancer and S100P methylation in peripheral blood by multicenter case-control studies

artículo científico publicado en 2017

The cellular ratio of immune tolerance (immunoCRIT) is a definite marker for aggressiveness of solid tumors and may explain tumor dissemination patterns

artículo científico publicado en 2013

The impact of human adipose tissue-derived stem cells on breast cancer cells: implications for cell-assisted lipotransfers in breast reconstruction

artículo científico publicado en 2017

The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemestane in the phase IIIb 4EVER trial

scientific article published on 02 October 2018

The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer

artículo científico publicado en 2012

The role of genetic breast cancer susceptibility variants as prognostic factors

artículo científico publicado en 2012

Use of Taxanes in Metastatic HER2-negative Breast Cancer - a Status Report

scientific article published on 21 April 2020

Utility of the CPS+EG staging system in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with neoadjuvant chemotherapy

artículo científico publicado en 2015

What is the evidence for lymphadenectomy in presumed early ovarian cancer?

artículo científico publicado en 2019

Preclinical evaluation of peptide-based radiotracers for integrin αvβ6-positive pancreatic carcinoma

scientific article published on 10 May 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda